Guest Kevin 4

What Happened
Kevin Guest, CEO and Executive Chairman of USANA Health Sciences (USNA), reported the conversion/vesting of 7,856 restricted stock units (RSUs) into common shares on 2026-02-27. To satisfy tax withholding, 3,328 of those shares were surrendered/covered at $21.52 per share, generating $71,619. Net shares delivered to Guest were roughly 4,528 shares (7,856 vested minus 3,328 withheld). The filing shows the derivative conversion (code M) and tax withholding (code F).

Key Details

• Transaction date: 2026-02-27; Form 4 filed 2026-03-03 (reports the 2/27 transactions).
• Conversion: 7,856 RSUs converted to common stock (reported as derivative exercise/conversion, code M).
• Tax withholding/disposition: 3,328 shares withheld/disposed at $21.52 each, totaling $71,619 (code F).
• Net shares received: ~4,528 shares.
• Shares owned after transaction: Not specified in the filing.
• Footnotes: F1 — each RSU equals the right to one USNA common share; F2 — these RSUs vest 25% on the anniversary of Feb 27, 2025 (vesting schedule disclosed).
• No indication in the filing of a 10b5-1 plan or other trading plan; the sale here is a tax-withholding event, not an open-market sell.

Context
This transaction appears to be a routine vesting/conversion of RSUs with shares withheld to cover tax obligations (common practice). Derivative code M simply indicates conversion/exercise of an equity-based award; code F indicates shares were used to satisfy tax withholding. Such withholding sales are administrative and do not necessarily signal the insider’s view on the company.